Riskpilot← Back to searchSign inGet full accessNORDIC NEUROSTIM ApS
APSBankruptCVR 35245170Niels Jernes Vej 10Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik · NACE 721900Est. 20131 employees
Revenue 2015
DKK -2,1M
+14% vs 2014
EBITDA margin
248.2%
-33% vs 2014
Equity ratio
86.5%
Financial strength
Net profit 2015
DKK -4,4M
-42% vs 2014
| Revenue | DKK -2,1M | +14% |
| EBITDA | DKK -5,3M | -33% |
| Net profit | DKK -4,4M | -42% |
| Total assets | DKK 3,7M | -16% |
| Equity | DKK 3,2M | -21% |
| Employees | 1 | — |
Legal name
NORDIC NEUROSTIM ApS
CVR number
35245170
Legal form
Anpartsselskab
NACE code
721900 · Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Founded
13. maj 2013
Share capital
DKK 247.758
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2015-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af tre bestyrelsesmedlemmer eller af Selskabets administrerende direktør og bestyrelsesformanden i forening
Address
Niels Jernes Vej 10
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 |
|---|---|---|---|
| Revenue | -628 | -1.858 | -2.124 |
| Staff expenses | -516 | -2.103 | -3.148 |
| EBITDA | -1.144 | -3.961 | -5.272 |
| Depreciation & amort. | -360 | -3 | -10 |
| EBIT | -1.505 | -3.964 | -5.282 |
| Net financials | 0 | -4 | -2 |
| Profit before tax | -1.505 | -3.967 | -5.284 |
| Tax | -275 | -849 | -870 |
| Net profit | -1.230 | -3.119 | -4.414 |
| Item | 2013 | 2014 | 2015 |
|---|---|---|---|
| Total assets | 2.834 | 4.448 | 3.734 |
| Equity | 2.632 | 4.066 | 3.229 |
| Long-term debt | 0 | 0 | 0 |
| Short-term debt | 203 | 382 | 505 |
| Total debt | 203 | 382 | 505 |
EBITDA margin
-527223200.0%
This company
15.8%
Market median
-3336855796% vs market
20132015
Equity ratio
86.5%
This company
38.2%
Market median
+126% vs market
20132015
Return on equity
-136.7%
This company
18.4%
Market median
-843% vs market
20132015
Net profit margin
-441388400.0%
This company
8.1%
Market median
-5449239606% vs market
20132015
Asset turnover
-0.57×
This company
1.12×
Market median
-151% vs market
20132015
Debt / equity
0.16×
This company
0.62×
Market median
+74% vs market
20132015
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
KH Management | Management | 2013 – 2016 |
LG Chief Executive Officer | Chief Executive Officer | 2016 – 2016 |
| Name | Role | Member since |
|---|---|---|
| Former (7) | ||
| Chairman | 2013 – 2015 | |
| Board of Directors | 2013 – 2015 | |
| Board of Directors | 2013 – 2016 | |
| Chairman | 2015 – 2016 | |
| Board of Directors | 2015 – 2016 | |
| Board of Directors | 2016 – 2016 | |
| Board of Directors | 2013 – 2016 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 33.33–49.99% | 33.33–49.99% | 2015 | |
| Company | 25–33.32% | 25–33.32% | 2015 | |
| Company | 33.33–49.99% | 33.33–49.99% | 2014 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NORDIC NEUROSTIM ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kristian Hennings | Management | 0 companies |
| Lise Grove | Chief Executive Officer | 0 companies |
| Jon Ingi Benediktsson | Chairman | 0 companies |
| Jan Bertholdt Hansen | Board of Directors | 0 companies |
| Peter Rasmussen | Board of Directors | 0 companies |
| Morten Heide | Chairman | 0 companies |
| Marie-Louise Little | Board of Directors | 0 companies |
| Finn Winchler Andersen | Board of Directors | 0 companies |
| Ole Kæseler Andersen | Board of Directors | 0 companies |